Vitafer-Fol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitafer-Fol

What is Vitafer-Fol?

Vitafer-Fol is a hematinic pharmaceutical preparation designed to address specific nutritional deficiencies related to red blood cell production. It belongs to a class of medications known as iron supplements, typically formulated as a combination product to support hematological health.

Composition and Action

The primary components of Vitafer-Fol are iron and folic acid (Vitamin B9). These two nutrients play a critical role in the synthesis of hemoglobin and the maturation of red blood cells.

  • Iron: This mineral is an essential constituent of hemoglobin, the protein in red blood cells responsible for transporting oxygen from the lungs to the rest of the body. When iron levels are insufficient, the body cannot produce enough healthy oxygen-carrying red blood cells.
  • Folic Acid: A water-soluble B-vitamin that is necessary for DNA synthesis and cell division. In the context of blood health, folic acid is required for the proper formation and development of nucleated red blood cells in the bone marrow.

Therapeutic Purpose

Vitafer-Fol is utilized to manage and prevent iron-deficiency anemia and megaloblastic anemia caused by folic acid deficiency. By providing these essential nutrients, the medication helps to restore depleted stores and maintain normal blood parameters.

It is often used in clinical situations where nutritional requirements are increased or where dietary intake is insufficient to meet the body's physiological demands. This includes various stages of life or specific health conditions where maintaining optimal iron and folate levels is necessary for systemic function.

Regulatory References

  1. Iron Supplementation
  2. Folic Acid

What side effects are possible with Vitafer-Fol?

Possible Side Effects and Safety Information

The safety profile for this combination of Ferrous Sulfate and Folic Acid is primarily characterized by effects related to the iron component and is defined by official regulatory documents.


Adverse Reaction Scope

The most frequently documented adverse effects are classified as occasional or common and involve the Gastrointestinal disorders system. These typically include nausea, constipation, diarrhea, vomiting, and abdominal discomfort.

A non-harmful and expected effect of the iron component is the blackening of the stool, which results from unabsorbed iron and is explicitly noted in labeling.


Serious Adverse Reactions and Safety Constraints

The regulatory label includes a mandatory, high-level warning regarding the inherent risk of fatal accidental poisoning in children under 6 years of age from acute overdose of iron-containing products.

Serious, though rare, reactions documented in post-marketing surveillance include severe hypersensitivity reactions up to anaphylaxis.

Official safety constraints also note that the tablet should not be sucked, chewed, or kept in the mouth to prevent the risk of localized lesions, such as mouth ulcerations or oesophageal lesions.


Population-Specific Considerations

Safety is constrained by specific pre-existing conditions. The product is generally contraindicated in patients with conditions of iron overload, such as hemochromatosis.

For the Folic Acid component, a significant safety note specifies that it may mask the hematological signs of an untreated Vitamin B12 deficiency (Pernicious Anemia) while allowing potential neurological damage to continue.

Overdose and Emergency Response

Overdose involving this combination product is primarily characterized by the severe, multi-stage toxicity of the iron salt component. The officially documented clinical presentation typically begins with an acute gastrointestinal phase, marked by severe vomiting, diarrhea, intense abdominal pain, and potentially the vomiting of blood (hematemesis). This may be followed by a deceptive latent period before progression to serious systemic toxicity.

Severe Manifestations and Outcomes

Severe overdose carries documented risks of life-threatening complications, including shock, severe hypotension, and circulatory collapse. Other serious manifestations listed in regulatory information include severe metabolic acidosis, convulsions, and delayed hepatic failure. Any suspected ingestion of a toxic amount necessitates immediate and mandatory medical intervention.

Emergency Actions and Management

Any suspected overdose requires individuals to seek immediate medical attention and contact emergency services or a Poison Control Center without delay. Official prescribing information confirms that treatment protocols include specific systemic chelation therapy using the antidote Deferoxamine Mesylate, along with symptomatic and supportive measures for fluid/electrolyte imbalance and acidosis. Due to the documented risk of delayed toxic relapse, hospitalization and close monitoring are required. Regulatory authorities explicitly highlight that overdose in children poses a critically high risk of fatality.

Therapeutic Uses of Vitafer-Fol

What Vitafer-Fol Treats: Main Uses and Benefits

The therapeutic application of this combination product is used in situations involving certain distressing symptoms linked to nutritional shortages and systemic imbalance. Daily iron and folic acid supplementation is considered relevant in supporting health during periods of deficiency risk.


This preparation is generally used to treat established cases of nutritional anemia, which includes iron-deficiency anemia and folate-deficiency anemia, and is commonly applied in prophylactic contexts during pregnancy or following periods of significant blood loss. By providing these essential components, the medication supports overall blood health during these conditions. It assists with managing symptom clusters that create noticeable physiological strain, such as chronic, unexplained fatigue, profound weakness, and diminished physical stamina.

“The therapeutic support assists with managing symptoms related to systemic imbalance, helping to ease the overall symptom load.”

The prophylactic use is applied in clinical settings that involve heightened systemic burden during high-demand physiological states.


Quick Fact: Relief for Anemia-Related Fatigue The supportive benefit helps to improve day-to-day comfort during symptomatic periods by supporting general well-being during symptomatic phases.

Regulatory References

  1. World Health Organization (WHO) has highlighted

Eligibility and Restrictions for Use

Population Exclusions and Absolute Contraindications

Use of this medicine is strictly contraindicated for several populations as defined by regulatory labeling. Individuals must not use Vitafer-Fol if they have a known hypersensitivity to any of its components. The medicine is prohibited for patients with existing iron overload disorders, such as haemochromatosis or haemosiderosis, or for those receiving iron through injection or repeated blood transfusions. A major restriction applies to patients with untreated Vitamin B12 deficiency (pernicious anemia), as the folate component can mask the neurological damage associated with that condition.

Age and Conditional Eligibility Rules

Official labeling carries an Important Warning requiring the product be kept out of the reach of children, as accidental iron overdose is a leading cause of fatal poisoning in children under six years of age. Use of specific oral tablet forms is generally not recommended for children under 12 years. For adults, use is generally permitted. However, caution is advised for patients with active gastrointestinal conditions, including peptic ulceration or inflammatory bowel disease. Use during pregnancy and lactation is generally established as safe and often recommended for deficiency prophylaxis.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official government regulatory actions and standard pharmacological texts identify specific interaction risks associated with products marketed as Vitafer-Fol or Vitafer-L Gold, based on both their declared ingredients (iron and folic acid) and undeclared substances found in some variants.

Documented Interaction Domains

Interacting Substance/Class Mechanism & Required Action
Nitrates (e.g., Nitroglycerin) Severe Pharmacodynamic Risk: Co-administration with the undeclared active pharmaceutical ingredient (tadalafil) found in some variants can cause a dangerous, significant drop in blood pressure. Official warnings advise against use.
Tetracyclines & Quinolones Decreased Absorption (Chelation): The iron component binds to these antibiotics in the gastrointestinal tract, reducing the effectiveness of both medicines. Timing separation is required.
Antacids Decreased Iron Absorption: These products can reduce the absorption of the iron component, diminishing its systemic exposure.
Thyroid Preparations Decreased Bioavailability: The iron component can interfere with the absorption of thyroid hormone medications.

Summary of Interaction Constraints

The primary constraints involve timing separation between administration of the iron component and substances like antibiotics or antacids to preserve medicinal product efficacy. Additionally, a critical restriction on use is mandated by official regulatory bodies concerning the specific risk posed by the undeclared ingredient (tadalafil) interacting with nitrates. This combination has been identified by government agencies as potentially life-threatening.

Mechanism of Action

Vitafer-Fol operates by intervening directly in two distinct, non-interchangeable metabolic pathways essential for manufacturing functional red blood cells ( RBCs). The mechanism provides critical substrates, a functional approach that differs from mechanisms based on direct pathway modulation.

DNA Synthesis and Cellular Proliferation (Folic Acid)

The Folic Acid component is converted within the cell into active cofactors that are essential for the one-carbon cycle. These cofactors donate methyl units required for the de novo synthesis of DNA purines and thymidylate. This fundamental action supports the rapid division and proper nuclear maturation of RBC precursors, thereby facilitating the synthesis necessary for appropriate cellular morphology.

Hemoglobin Assembly and Oxygen Capacity (Ferrous Sulfate)

The Ferrous Sulfate component supplies the highly utilized ferrous ion ( Fe^2+). This ion is the absolute requirement for the final assembly of the Heme molecule, which in turn forms the functional core of Hemoglobin ( Hb). By provisioning this structural raw material, the mechanism facilitates the proper filling of RBCs with Hb, thereby supporting the cell's systemic oxygen transport function.

Synergistic Restoration of Erythropoiesis

The combination's action exhibits synergy: the folate mechanism addresses the cellular requirement for proliferation and maturation, while the iron mechanism addresses the cell's requirement for functional content. This coordinated effort addresses the dual requirements for RBC production, supporting the synthesis of normocytic, normochromic erythrocytes.

Dosage and Administration Information

Vitafer-Fol, a combination of a ferrous salt and folic acid, is strictly designated for oral administration as a solid preparation, typically a tablet or capsule. The preparation is conventionally prescribed for a once-daily regimen. The standard approach for correction of established nutritional deficiencies involves treatment for a course of several months, often continuing for approximately three months after the deficiency has been resolved to ensure full repletion of physiological stores. The maximum duration of continuous use may be specified in the prescribing information, often not exceeding six months for uncomplicated deficiency.

Regarding administration timing, the preparation is best absorbed when taken on an empty stomach, ideally one hour before or two hours after a meal. This timing preference is noted in official labels to maximize the bioavailability of the components. If this timing causes significant gastrointestinal discomfort, the preparation may be taken with food to improve patient tolerance and adherence. The tablet or capsule must be swallowed whole with water; they should not be crushed, sucked, or chewed, a restriction intended to preserve the intended release characteristics of the components. Furthermore, to prevent reduced absorption, the preparation should not be taken concurrently with milk, tea, or coffee. Specific dosing guidelines are established for high-demand states, such as a daily regimen during pregnancy, reflecting the increased systemic need for both essential nutrients.

Recent Clinical Evidence

Recent Clinical Evidence

This section describes the clinical and preclinical studies that have evaluated Vitafer-Fol (a combination of ferrous fumarate and folic acid). It is important to understand that this summary reports on research findings and does not constitute medical advice or a recommendation for treatment.


Clinical Efficacy Studies

Studies have evaluated the association between the drug and changes in the severity and frequency of symptoms related to iron deficiency anemia (IDA), particularly in pregnant and postpartum women. The research generally involved randomized, controlled trials. These trials monitored changes in key hematological parameters over several weeks.

  • Primary Outcome: Research explored the findings related to hemoglobin (Hb) and serum ferritin levels in participants receiving the drug. These studies found that the regimen was associated with an increase in mean Hb levels and ferritin concentration in patients with IDA.
  • Inflammation: Clinical trials evaluated the findings related to iron status, which is often measured through biological markers. Research assessed whether a change in iron status occurred following treatment.

Safety and Tolerability

Clinical trials recorded and analyzed the reported adverse events associated with the combination. Gastrointestinal (GI) side effects are commonly reported with oral iron supplements, and studies examined the tolerability of this specific formulation.

  • Adverse Event Monitoring: The study protocol advised participants to consult their doctor if they experienced any adverse events. Reported events included gastrointestinal disturbances (such as constipation or nausea) and local reactions at the injection site (where applicable in comparative studies).
  • Compliance: Studies have noted that the occurrence of GI side effects may be a factor influencing patient compliance with the prescribed regimen.

Comparisons

Research has been conducted comparing the use of ferrous fumarate and folic acid combinations to other oral iron formulations, such as ferrous sulfate or carbonyl iron, to investigate differences in patient outcomes and tolerability.

Key Studies & References

  1. Clinical Management of Iron Deficiency Anemia in Pregnancy: ACOG Practice Bulletin, Number 236

Frequently Asked Questions (FAQ)

Common questions about Vitafer-Fol (FAQ)


Q: Is Vitafer-Fol only for people with anemia?

According to official product descriptions, Vitafer-Fol is used to address iron deficiency anemia. However, it is also commonly prescribed for general vitamin and mineral supplementation, particularly in cases of established deficiency or for prophylaxis (prevention), such as during pregnancy or lactation. The use of the product is generally determined by a healthcare provider based on a diagnosed deficiency or condition.


Q: What is the difference between Vitafer-Fol and a standard iron supplement?

Vitafer-Fol is defined as a fixed-dose combination product containing both iron (a mineral salt) and folic acid (a B-vitamin). Standard iron supplements usually contain only the iron component. This dual formula supports both the hemoglobin content and the proper cell maturation needed for red blood cell production.


Q: Why is Vitafer-Fol commonly recommended during pregnancy?

Official health guidance, including recommendations from the WHO, suggests a daily iron and folic acid supplement for pregnant people. This is because pregnancy significantly increases the systemic need for both essential nutrients. Regulatory information advises that prophylaxis (prevention of deficiency) is often justified for the remainder of pregnancy after the first trimester.


Q: Are there any long-term health concerns associated with using Vitafer-Fol?

Regulatory warnings state that the prolonged use of iron salts may potentially lead to an iron storage disease (hemochromatosis). The length of treatment is typically determined by a healthcare provider based on the patient's individual condition. Regulatory warnings indicate that overdose is a serious risk, particularly in children, and may potentially result in severe systemic effects, including damage to organs like the liver.


Q: How long do initial side effects from Vitafer-Fol usually last?

According to public information guides based on regulatory labels, gastrointestinal side effects like constipation, diarrhea, or stomach cramps are common but usually temporary. These effects often diminish as your body adjusts to the medication.


Q: Are the side effects of Vitafer-Fol different for older adults?

Regulatory documents note that constipation can be a particular concern with continual administration of this product, especially in older patients. This condition may potentially lead to faecal impaction, which is a severe blockage of the bowels.


Q: Is there an interaction between Vitafer-Fol and common antibiotics?

Yes, the iron component in this medicine can interfere with the absorption of certain antibiotics, specifically tetracyclines and quinolones. Official guidelines advise separating the administration of these medicines by 2 to 4 hours to preserve the effectiveness of both.


Q: Can I take Vitafer-Fol at the same time as my calcium or magnesium supplements?

Official guidance states that supplements containing large amounts of calcium, such as antacids, should not be taken at the same time as Vitafer-Fol. Calcium can interfere with the body's ability to absorb iron, reducing the medicine's effectiveness. Regulatory information suggests separating the administration, such as by 2 hours.


Q: Does Vitafer-Fol interact with any types of blood pressure medication?

Regulatory documents state that the iron component reduces the absorption of levothyroxine, which is a thyroid hormone often used to treat an underactive thyroid. Additionally, due to an undeclared ingredient found in certain variants of the product, government warnings have noted a severe risk when co-administered with nitrates (used for chest pain).


Q: Should I avoid dairy products entirely while on Vitafer-Fol?

Dairy products like milk, cheese, and yogurt contain calcium, which can decrease the medicine's effectiveness by hindering iron absorption. Official guidelines generally advise avoiding dairy products for at least 2 hours before or after taking the medicine.


Q: Are there specific food restrictions officially described for Vitafer-Fol users?

Official guidelines describe several foods and beverages that may interfere with iron absorption. These include coffee, tea, dairy products, fish, meat, liver, and whole grain or fortified cereals. Users are generally advised to separate these items from the medicine by at least 2 hours to maximize effectiveness.


Q: Can I safely consume alcohol while being treated with Vitafer-Fol?

Official information states that alcohol consumption may be permitted. However, some regulatory labels advise caution if there is a known history of alcohol use or abuse. A healthcare provider can offer guidance specific to an individual's medical history.


Q: Why is separating the dosage of Vitafer-Fol from certain foods sometimes advised?

Certain foods, such as tea, coffee, and dairy products, are known to decrease the body's ability to absorb the iron component. Therefore, separating the dosage from these items by a few hours is advised to maximize the absorption and effectiveness of the medicine.


Q: How quickly should a person expect to feel the effects of Vitafer-Fol?

Most individuals who experience symptoms of iron deficiency begin to feel better after 3 to 4 weeks of starting treatment. However, official information indicates that it may take 2 to 4 months for the medicine to fully replenish the body's iron stores and complete its effect.


Q: What is the typical length of time people take Vitafer-Fol?

The typical length of treatment is determined by a healthcare professional based on the individual's needs. Regulatory documents state that the duration should generally not exceed 3 months after the underlying anemia has been corrected.


Q: What is the recommended course of treatment for low iron levels using Vitafer-Fol?

Treatment typically involves a once-daily regimen taken until the iron deficiency is resolved, which can take several months. Regulatory guidance suggests that the medicine is best absorbed when taken on an empty stomach. The full duration of the course should generally not exceed 3 months after correction of anemia.


Q: How soon after starting Vitafer-Fol do iron levels usually begin to rise?

While subjective symptom relief may occur sooner, official guidance indicates that blood tests are often performed within the first 4 weeks of treatment to monitor effectiveness and see if the rise in iron levels is measurable in the blood.


Q: What are the common indicators that Vitafer-Fol is working?

The most common indicators that the medicine is working are the improvement or resolution of symptoms associated with iron deficiency. These often include a reduction in fatigue and an improvement in other signs like paler than usual skin.


Q: Is Vitafer-Fol safe for use during all stages of pregnancy?

Regulatory information states that use during the first trimester of pregnancy should be avoided unless there is definite evidence of iron deficiency. However, deficiency prophylaxis (prevention) is generally considered justified for the remainder of pregnancy.


Q: Can men use Vitafer-Fol, or is it exclusively for women's health?

Vitafer-Fol is prescribed to address iron deficiency and the resulting anemia, a condition that can affect anyone, regardless of sex. The use of the medicine is therefore not officially restricted to women's health.


Q: Is Vitafer-Fol appropriate for children or adolescents?

According to regulatory documents, the product is generally not recommended for pediatric use. Furthermore, specific oral tablet forms are typically warned against for administration to children under the age of 12.

--ोस

Q: Are there any warnings for people with underlying kidney or liver conditions?

Regulatory precautions advise caution for patients with a known history of liver problems. Additionally, official information notes that iron supplementation is often a factor in managing anemia that results from certain chronic conditions, such as chronic kidney disease.


Q: Does taking Vitafer-Fol affect blood sugar levels for people with diabetes?

The regulatory label notes that severe iron overdose may cause metabolic changes, including hyperglycaemia (high blood sugar). However, the effect of general, intended use on blood sugar levels for people with diabetes is not specified in this context.


Q: Is Vitafer-Fol available without a prescription or a doctor's recommendation?

The iron supplement component is commonly available Over-the-Counter ( OTC). However, specific combination products like Vitafer-Fol or certain higher-dose formulations may only be available by prescription in some jurisdictions.

How should Vitafer-Fol be stored and disposed of?

How to Store and Dispose of Vitafer-Fol?

Regulatory requirements for this combination product, which contains iron and folic acid, focus on maintaining stability and ensuring child safety.


Storage Conditions

The medicine must be stored at controlled room temperature, typically below 30°C (86°F), and should not be frozen. To prevent chemical degradation, keep the product protected from light and moisture by storing it in the original container with the lid tightly closed.


Safety and Disposal

Due to the iron content, it is an official mandate to keep Vitafer-Fol out of the sight and reach of children to prevent accidental poisoning. Unused or expired medicine must not be thrown into household trash or wastewater. Disposal must follow local regulatory requirements for unused medicinal products, often requiring return to a pharmacy or designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vitafer-Fol found in:

A-Z Index: